Developing new methods to create nitrogen-containing molecules for pharmaceuticals
Strategies for the Catalytic Synthesis of Nitrogen-Containing Molecules
This study is working on new ways to make important chemical ingredients that can help create better medicines, which could lead to new treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10857263 on NIH RePORTER |
What this research studies
This research focuses on creating innovative methods for synthesizing nitrogen-containing and fluorine-containing chemical building blocks, which are essential for many pharmaceuticals. The project aims to develop new reagents and catalytic strategies to enhance the efficiency and selectivity of these synthesis processes. By exploring novel classes of compounds, the research seeks to enable the rapid assembly of complex molecules that can lead to new drug-like candidates. Patients may benefit from advancements in drug development that arise from these improved synthetic methods.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new pharmaceuticals developed from these nitrogen-containing molecules.
Not a fit: Patients with conditions that do not require nitrogen-containing drugs or those who are not responsive to pharmaceutical interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective medications for various health conditions.
How similar studies have performed: Other research in the field of organic synthesis has shown success in developing new methods for drug synthesis, indicating that this approach has potential for impactful results.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Malcolmson, Steven Joseph — Duke University
- Study coordinator: Malcolmson, Steven Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.